ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 154

Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound

Aneela Mian1, Khaldoun Chaabo2, Julekha Wajed3, Bruce W. Kirkham4 and Toby Garrood5, 1Academic Rheumatology, King's College London, London, United Kingdom, 2Rheumatology, Guy's and St Thomas NHS Trust, London, United Kingdom, 3Rheumatology, Guys' and St Thomas' NHS Trust, London, United Kingdom, 4Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, 5Rheumatology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia, rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Up to 20% of patients with RA have coexisting fibromyalgia(FM). This can make treatment decisions challenging in clinical practice as disease activity scores can be high despite limited clinical evidence of active synovitis. Recent work has suggested that a tender joint count (TJC) minus swollen joint count (SJC)(each out of 28) of ≥7 identifies patients with co-existing FM (‘fibromyalgic’ RA) with high sensitivity and specificity. Ultrasound (US) of joints particularly power Doppler is predictive of outcomes in RA patients. The aim of this study was to determine whether RA patients with active disease also meeting existing criteria for fibromyalgia had significantly less joint inflammation on ultrasound than those who did not.

Methods: 47 RA patients with DAS28 scores >2.6 were recruited. Patients completed questionnaires including the Widespread Pain Index(WPI), PHQ9(depression), GAD7(anxiety), PHQ15(somatisation), FACIT-fatigue, HAQ and global health assessment VAS.  The TJC, SJC, Symptom Severity Score(SSS) and the number of FM soft-tissue tender points were recorded by a physician. Patients underwent a 22-joint US scan by a second blinded physician of the wrists, MCPJs and PIPJs bilaterally. Grey scale(GS) and power Doppler(PD) scores were recorded for each joint on a semiquantitative scale (0-3) for each patient. FM patients were grouped according to the ACR 1990 classification criteria and TJC-SJC >7 individually and in combination. Differences between groups were tested using the Mann-Whitney U test. Significance was set at p<0.05

Results: GS scores were significantly lower in patients meeting ACR (GS score 16.7,p=0.025), TJC-SJC (16.7,0.034) or both criteria (15.4, 0.022) than in those who did not (21.8). PD scores were not significantly different for the individual criteria but when combined the scores for patients meeting both criteria were significantly lower compared with patients not meeting these criteria (PD score 2.94 vs 8.33, p=0.028). Significantly higher scores were seen for depression, anxiety, disability and somatization scores in patients meeting either or both FM criteria compared with those who did not.

Conclusion: Our findings show that RA patients who meet the 1990 ACR criteria for FM and who have a TJC minus SJC of ≥7 have significantly lower levels of synovitis on GS and PD US. This suggests that it may be possible to use clinical measures to identify patients not in DAS28 clinical remission into those with higher or lower levels of synovitis on US. Thus there may be a role for composite tools in clinical practice to stratify patients into those who may benefit from continued escalation of immunosupression and those who may benefit from alternative management strategies focussing on improving levels of depression, anxiety and fatigue. We are currently conducting a larger study to explore this further. 

 

TJ – SJ count ≥7

Pollard et al

n=26

≥11 Fibromyagic tender points

ACR 1990 classification

n=20

Both

n=17

Grey scale

16.7 (6.96)

p=0.034

16.7 (8.61)

p=0.025

15.41 (6.38)

p=0.022

Power Doppler

4.44 (5.067)

p=0.080

5.11 (10.10)

p=0.094

2.94 (3.09)

p=0.028

Table 1.  Mean score, (SD), p value


Disclosure: A. Mian, None; K. Chaabo, None; J. Wajed, None; B. W. Kirkham, None; T. Garrood, None.

To cite this abstract in AMA style:

Mian A, Chaabo K, Wajed J, Kirkham BW, Garrood T. Clinical Features of Fibromyalgia in Patients with Rheumatoid Arthritis Predict Lower Power Doppler Scores on Ultrasound [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/clinical-features-of-fibromyalgia-in-patients-with-rheumatoid-arthritis-predict-lower-power-doppler-scores-on-ultrasound/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-of-fibromyalgia-in-patients-with-rheumatoid-arthritis-predict-lower-power-doppler-scores-on-ultrasound/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology